Fieldpoint Private Securities’s AtriCure ATRC Stock Holding History

Fieldpoint Private Securities’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$72K	Sell	1,759 -5	-0.3%	-$237	0.02%	416
2022 Q1	$116K	Hold	1,764	–	–	0.02%	403
2021 Q4	$123K	Hold	1,764	–	–	0.02%	397
2021 Q3	$123K	Hold	1,764	–	–	0.03%	383
2021 Q2	$129K	Sell	1,764 -21	-1%	-$1.53K	0.03%	368
2021 Q1	$117K	Sell	1,785 -520	-23%	-$32K	0.03%	376
2020 Q4	$128K	Buy	+2,305	New	+$99.7K	0.03%	358

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fieldpoint Private Securities's ATRC Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its AtriCure (ATRC) stake by 0.28% in Q2 2022, selling an estimated $237 and leaving 1,759 shares worth $72K. The position accounts for 0.02% of the portfolio, ranked #416.

Fieldpoint Private Securities first reported a position in ATRC in Q4 2020 and has held it in 7 quarters since. The position peaked at $129K in Q2 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

Fieldpoint Private Securities held 1,759 shares of AtriCure worth $72K as of Q2 2022.
Fieldpoint Private Securities sold 5 AtriCure shares in Q2 2022, an estimated $237.
AtriCure made up 0.02% of Fieldpoint Private Securities's portfolio in Q2 2022, its #416 holding.
Fieldpoint Private Securities first reported a position in AtriCure in Q4 2020 and has held it in 7 quarters since.
Fieldpoint Private Securities's AtriCure position peaked at $129K in Q2 2021.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.